Literature DB >> 16935763

Prevalence of obesity and metabolic syndrome in Taiwan.

Lee-Ching Hwang1, Chyi-Huey Bai, Chien-Jen Chen.   

Abstract

BACKGROUND/
PURPOSE: Obesity and metabolic syndrome (MS) are major risk factors for the development of type 2 diabetes and cardiovascular diseases (CVD). This study estimated the prevalence of obesity and MS in Taiwan.
METHODS: Data from a nationwide cross-sectional population-based survey of 5936 participants (2815 men, 3121 women; age range, 20-79.9 years) in 2002 were analyzed. Obesity was defined as a body mass index (BMI) > or = 27 kg/m(2) according to the criteria of the Department of Health in Taiwan. The prevalence of MS was estimated using the definitions of the modified Adult Treatment Panel III (ATP III), the International Diabetes Federation for Chinese (MS-IDF(C)) and the MS criteria for Taiwanese (MS-TW).
RESULTS: The overall prevalence of obesity in men was significantly greater than in women (19.2% vs. 13.4%, p < 0.0001). The age-standardized prevalence of MS was 15.7% by the modified ATP III criteria, 14.3% by the MS-IDF(C) criteria and 16.4% by the MS-TW criteria. The prevalence of obesity and MS significantly increased with age (trend test, p < 0.0001) in men and women. The risk of MS and its components increased significantly with BMI, and showed a marked increase with BMI > or = 24 kg/m(2). MS as classified by the MS-IDF(C) criteria failed to identify subjects at high risk of CVD who did not have abdominal obesity, including those with hypertension, type 2 diabetes and dyslipidemia.
CONCLUSION: This study found a high prevalence of obesity and MS in Taiwan. The definitions of MS by the modified ATP III and MS-TW criteria were better able to detect high CVD risk than the MS-IDF(C) criteria.

Entities:  

Mesh:

Year:  2006        PMID: 16935763     DOI: 10.1016/S0929-6646(09)60161-3

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.282


  107 in total

1.  Association of surrogate and direct measures of adiposity with risk of metabolic syndrome in rural Chinese women.

Authors:  Fengxiu Ouyang; Jonathan Necheles; Binyan Wang; Wei Ma; Zhiping Li; Xue Liu; Genfu Tang; Houxun Xing; Xiping Xu; Scott A Venners; Wendy J Brickman; Katherine Kaufer Christoffel; Donald Zimmerman; Xiaobin Wang
Journal:  Eur J Nutr       Date:  2009-04-01       Impact factor: 5.614

Review 2.  The metabolic syndrome.

Authors:  Marc-Andre Cornier; Dana Dabelea; Teri L Hernandez; Rachel C Lindstrom; Amy J Steig; Nicole R Stob; Rachael E Van Pelt; Hong Wang; Robert H Eckel
Journal:  Endocr Rev       Date:  2008-10-29       Impact factor: 19.871

3.  Metabolic syndrome as an underlying disease entity and its relationship to subclinical atherosclerosis in Andean Hispanics.

Authors:  Diana A Chirinos; Josefina Medina-Lezama; William Arguelles; Ronald Goldberg; Neil Schneiderman; Zubair Khan; Oscar O Morey; Muhammad Waheed Raja; Roberto Paz; Julio A Chirinos; Maria M Llabre
Journal:  Metab Syndr Relat Disord       Date:  2013-11-08       Impact factor: 1.894

4.  Metabolic syndrome in Iranian patients with systemic lupus erythematosus and its determinants.

Authors:  Alimohammad Fatemi; Azadeh Ghanbarian; Zahra Sayedbonakdar; Mehdi Kazemi; Abbas Smiley
Journal:  Clin Rheumatol       Date:  2018-01-05       Impact factor: 2.980

5.  Factors affecting operative efficiency and post-operative convalescence in laparoendoscopic single-site (LESS) adrenalectomy.

Authors:  Yao-Chou Tsai; Chung-Hsien Chen; Ya-Hui Hu; Leay-Kiaw Er; Che-Hsiung Wu; Shih-Chieh Chueh; Victor Chia-Hsiang Lin
Journal:  Surg Endosc       Date:  2017-09-15       Impact factor: 4.584

Review 6.  Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders--a systematic review and meta-analysis.

Authors:  Alex J Mitchell; Davy Vancampfort; Kim Sweers; Ruud van Winkel; Weiping Yu; Marc De Hert
Journal:  Schizophr Bull       Date:  2011-12-29       Impact factor: 9.306

7.  The effectiveness of IDF and ATP-III in identifying metabolic syndrome and the usefulness of these tools for health-promotion in older Taiwanese.

Authors:  M M Chen; A C Tsai
Journal:  J Nutr Health Aging       Date:  2013-04       Impact factor: 4.075

8.  Clinical and virological characteristics post HBsAg seroclearance in hepatitis B virus carriers with hepatic steatosis versus those without.

Authors:  Chia-Ming Chu; Deng-Yn Lin; Yun-Fan Liaw
Journal:  Dig Dis Sci       Date:  2012-08-18       Impact factor: 3.199

9.  Association of soluble cell adhesion molecules with ankle-brachial index in a biethnic cohort of predominantly hypertensive individuals.

Authors:  Mahyar Khaleghi; Zeenat Ali; Thomas H Mosley; Stephen T Turner; Iftikhar J Kullo
Journal:  Clin Chem       Date:  2008-09-11       Impact factor: 8.327

10.  Gender difference on the development of metabolic syndrome: a population-based study in Taiwan.

Authors:  Lee-Ching Hwang; Chyi-Huey Bai; Chien-Jen Chen; Kuo-Liong Chien
Journal:  Eur J Epidemiol       Date:  2007-10-10       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.